Related Experiment Videos
Severe hyperprostaglandin E syndrome with hyperthyroidism--studies of pathogenetic mechanisms
V Fellman1, H Pihko, A Majander
1Children's Hospital, University of Helsinki, Finland.
Journal of Inherited Metabolic Disease
|January 1, 1996
Summary
This study details a severe variant of Hyperprostaglandin E syndrome, a rare disease, presenting with novel hyperthyroidism. The underlying pathology of this prostaglandin E2-related disorder remains elusive.
Area of Science:
- Endocrinology
- Rare Diseases
- Metabolic Disorders
Background:
- Hyperprostaglandin E syndrome is a rare genetic disorder characterized by renal and systemic symptoms.
- Typical manifestations include polyuria, hypercalciuria, hypokalemia, fever, diarrhea, and convulsions.
- The exact underlying pathology of this syndrome is not fully understood.
Observation:
- A severe variant of Hyperprostaglandin E syndrome was identified.
- This variant presented with significant pain and previously undescribed prostaglandin E2 (PGE2)-stimulated hyperthyroidism.
- Elevated urinary excretion of PGE2 and its metabolite were observed.
Findings:
- Urinary PGE2 and its metabolite levels were markedly increased.
- Investigation ruled out generalized mitochondrial disease as the cause.
- No deficiency was found in liver peroxisomal oxidases, suggesting these pathways are not the primary issue.
Implications:
- This case expands the clinical spectrum of Hyperprostaglandin E syndrome.
- The association with PGE2-stimulated hyperthyroidism offers new avenues for research.
- Further investigation is needed to elucidate the fundamental pathology of this rare disease.